chance for them to hit the obesity is low
But if they really find the needle spot
$crbp is going to up HARD
Talking about 20% of pt with severe GI upset and 20% with no effect shown on GLP-1
Trading right above cash level is fairly a good r/r
for oncology pipeline, they seem to have a real drug for HPV+ HNSCC
FDA source confirmed to @endpts that the 1st review team of Replimune's immunotherapy for advanced melanoma concluded RP1 should receive accelerated approval $XBI $BBC $IBB $REPL. And regulatory expert who was Oncology Branch 1 Chief in CBER till 11/25, Bross, said in reply to FDA alum @SeanKhozin LI post that there was interference
$slno
just saw an update from
FDA's Adverse Event Reporting System (FAERS)
on 4/3/26
reporting death for a 10 years girl died with pulmonary artery dilation on 12/12/25
please help me fact check this
its completly new from what we know